Pain Control in Children and Adolescent After Thoracic Surgery: The Effect of Gabapentin
Status:
Completed
Trial end date:
2020-12-03
Target enrollment:
Participant gender:
Summary
The study is performed in patients aged 5-18 years after thoracic surgery. The primary aim of
this trial is to determine whether the use of gabapentin as a component of multimodal
analgesic regiments reduces pain scores following thoracic surgery in pediatric patients. The
secondary objective of the trial are to evaluate whether the use of gabapentin reduces
postoperative anxiety scores and consumption of ropivacaine with fentanyl, decreases
side-effects, and improves patient satisfaction.
Phase:
Phase 4
Details
Lead Sponsor:
National Institute for Tuberculosis and Lung Diseases, Poland